Latest Content

Rusfertide Reduces Phlebotomy Need, Improves Quality of Life in Polycythemia Vera

June 11th 2025, 4:30pm

By Ryan Scott

Article

Treatment with the investigational therapeutic rusfertide has proven to be a potential treatment option for patients with polycythemia vera.

FDA Grants Priority Review to Zepzelca Combo for Small Cell Lung Cancer

June 11th 2025, 3:00pm

By Spencer Feldman

Article

FDA granted priority review to Zepzelca plus Tecentriq for first-line maintenance in extensive-stage small cell lung cancer.

How to Prepare for Self-Advocacy After a Cancer Diagnosis

June 11th 2025, 1:00pm

By Michelle Kirschner

Video

Patients can prepare for self-advocacy by bringing personal overviews to help care teams connect with them as individuals, explained Michelle Kirschner.

Oncology Nurse Amanda Snyder Turns Personal Experience Into Advocacy

June 10th 2025, 9:00pm

By Jeanine Pronio

Article

Amanda Snyder, a cancer survivor, became an oncology nurse to provide support she once lacked, now leading innovative therapies for patients.

Enhertu Combo May Offer Longer Control for HER2+ Breast Cancer

June 10th 2025, 8:00pm

By Dr. Sara M. Tolaney

Video

Enhertu with Perjeta nearly doubled progression-free survival versus standard treatment in metastatic HER2-positive breast cancer, study shows.

The LAURA Trial May Lead to a New Era of Care in Lung Cancer

June 10th 2025, 7:00pm

By Ryan Scott

Article

Dr. Suresh Ramalingam discusses how Tagrisso has ushered in a new era of care for patients with advanced EGFR+ non-small cell lung cancer.

A Letter to My 2009 Self, Newly Diagnosed With Breast Cancer

June 10th 2025, 5:00pm

By Brenda Denzler

Article

I survived breast cancer and medical trauma, but the road was brutal. Fifteen years later, I’m alive, scarred and still searching for peace.

Understanding Breast Cancer Biomarkers Drives Patient Treatment Decisions

June 10th 2025, 4:00pm

By Kristie L. Kahl

Article

Dr. Mabel Mardones educates patients on breast cancer subtypes, as well as treatment options for those with ER-positive, HER2-negative disease.

FDA Grants Fast Track Status to PHST001 for Ovarian Cancer Treatment

June 10th 2025, 3:18pm

By Spencer Feldman

Article

The FDA grants fast track designation to PHST001, an antibody targeting CD24, for advanced platinum-resistant and platinum-sensitive ovarian cancer.

Expanding on a New Way to Manage Polycythemia Vera Without Iron Deficiency

June 10th 2025, 1:00pm

By Aaron Gerds, MD, MS

Video

The VERIFY trial explores rusfertide to manage polycythemia vera without causing iron deficiency symptoms, Dr. Aaron Gerds explained.

I Sometimes Forget to Celebrate Survivorship

June 9th 2025, 9:00pm

By Mary Sansone

Article

Five years after my transplant for leukemia, I’m learning to focus on gratitude despite daily struggles, remembering that being alive is the greatest gift.

You Are Not Alone While Building a Support Team During Cancer Care

June 9th 2025, 8:00pm

By Michelle Kirschner

Video

Michelle Kirschner discusses the how patients can foster a strong network of supporters from diagnosis through survivorship.

When Treatment Ends, Support Shouldn’t Stop in Cancer Care

June 9th 2025, 7:00pm

By Ryan Scott

Article

Natalie Schnaitmann discusses the importance of self-advocacy and access to second opinions when symptoms are dismissed among young women with cancer.

The Gift of a Good Cancer Nurse

June 9th 2025, 5:00pm

By Martha Carlson

Article

When it comes to living with cancer, your nurses make a difference.

Zilovertamab Vedotin Plus Chemo Combo Shows Responses in R/R DLBCL

June 9th 2025, 4:01pm

By Silas Inman

Article

The antibody-drug conjugate zilovertamab vedotin plus Rituxan and chemotherapy showed an objective response rate of 56.3% in relapsed/refractory DLBCL.